↓ Skip to main content

Dental implants in immunocompromised patients: a systematic review and meta-analysis

Overview of attention for article published in International Journal of Implant Dentistry, November 2019
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#13 of 104)
  • Good Attention Score compared to outputs of the same age (69th percentile)

Mentioned by

1 policy source
3 tweeters


21 Dimensions

Readers on

61 Mendeley
Dental implants in immunocompromised patients: a systematic review and meta-analysis
Published in
International Journal of Implant Dentistry, November 2019
DOI 10.1186/s40729-019-0191-5
Pubmed ID

Fabian Duttenhoefer, Marc Anton Fuessinger, Yasmin Beckmann, Rainer Schmelzeisen, Knut A. Groetz, Martin Boeker


Impaired health conditions and related lack of adequate host healing are among the most important conditions that account for dental implant failure. Today clinicians face an increasing number of immunocompromised patients requesting implant-based rehabilitation. To provide clinical evidence for prospective decision-making, the aim of this systematic review and meta-analysis was to analyse the influence of immunodeficiency on dental implant survival. The study was conducted according to the PRISMA Statement and the principles of the Cochrane Collaboration. MEDLINE and Web of Science were searched. Results were calculated by the pooled incidence of implant loss. Reported odds ratios (OR) from fully adjusted models were preferred. Distinct risk estimates were synthesised with 95% confidence intervals. A total of 62 publications including 1751 endosseous implants placed in immunocompromised patients were included. For the follow-up of 24 months and longer, the mean survival rate of implants in patients with HIV was 93.1%, chemotherapy was 98.8%, autoimmune disease was 88.75%, after organ transplantation was 100%. Crohn's disease showed a significant effect on early implant failure and resulted in increased, however not significant, implant loss. No significant effect of immunocompromised conditions on implant survival was detectable. Implant-based therapy in immunocompromised patients should not aggravate the general morbidity and must not interfere in life-saving therapies. A careful risk stratification prior implant therapy is fundamental. To further decipher the role of immunosuppression on dental implantology, more data from controlled and randomised studies are needed.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 61 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 16%
Student > Bachelor 9 15%
Student > Postgraduate 6 10%
Student > Ph. D. Student 4 7%
Unspecified 3 5%
Other 9 15%
Unknown 20 33%
Readers by discipline Count As %
Medicine and Dentistry 24 39%
Nursing and Health Professions 5 8%
Biochemistry, Genetics and Molecular Biology 3 5%
Unspecified 2 3%
Computer Science 2 3%
Other 7 11%
Unknown 18 30%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 October 2021.
All research outputs
of 23,177,498 outputs
Outputs from International Journal of Implant Dentistry
of 104 outputs
Outputs of similar age
of 459,050 outputs
Outputs of similar age from International Journal of Implant Dentistry
of 2 outputs
Altmetric has tracked 23,177,498 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 104 research outputs from this source. They receive a mean Attention Score of 1.9. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 459,050 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them